Mayo Clinic Health System

Mayo Clinic Health System (MCHS) is a vital and growing part of the broader Mayo Clinic enterprise. As a community-based health care delivery system, MCHS operates independently within Mayo Clinic’s integrated practice model, with a distinct mission to provide high-quality care close to home in the communities it serves. MCHS includes 16 hospitals and more than 40 multi-specialty clinics, delivering care communities across Minnesota and Wisconsin and is home to 14k employees. With a vision to be a Category of One community health system, MCHS brings Mayo Clinic expertise to rural and regional populations—where providers see more than 600,000 unique patients and manage over 2 million outpatient visits annually. 

Mayo Clinic Health System Mission/Vision/Values

• Mission: To inspire hope and contribute to health and well-being by providing the best care to every patient through integrated clinical practice, education, and research.
• Vision: To be a Category of One Community Health System and provide Mayo Clinic care close to home.
• Value Statement: The needs of the patient come first.

Cancer Care at MCHS

The Hematology–Oncology service is a strategic priority for growth. It provides services in these communities through 18 physicians, 10 infusion centers across MCHS, and a strong team of advanced-practice providers, nurses, social workers, dietitians, and pharmacists and includes 3 community-based cancer centers, based in MCHS hospitals and clinics in La Crosse and Eau Claire, Wisconsin, and in Mankato, Minnesota. The MCHS sees over 3,000 new cancer cases per year (>2,200 of whom are seen in the La Crosse, Eau Claire, and Mankato community cancer centers alone) and has a close working relationship with the Mayo Clinic Comprehensive Cancer Center and colleagues in Mayo Clinic Rochester, MN. The overarching strategy is for MCHS to bring the expertise of Mayo Clinic to these communities and surrounding areas. At MCHS, patients have access to a full spectrum of health care options, with more than 100 medical and surgical services and specialties available throughout the system. When needed, patients transition seamlessly to highly specialized care for advanced and complex cancers at Mayo Clinic Comprehensive Cancer Center (MCCCC) in the Mayo Clinic Destination Medical Center campus in Rochester, Minnesota. 

The MCHS network provides a unique opportunity to transform rural community care nationally, via community-based research. The Mayo Clinic Cancer Center works closely with MCHS to advance research and run clinical trials to achieve its mission in community settings, especially rural settings. 

Position Overview/Search

The Mayo Clinic Health System (MCHS) seeks a visionary, strategic and inspirational leader to serve as the next Chair of the Hematology-Oncology department. The chair will lead MCHS to Category of One across the Hematology-Oncology practice. With an administrative and nursing partner, the chair is responsible for defining and implementing a strategic plan to ensure quality, safety, efficiency, patient experience and staff satisfaction. In collaboration with other leaders, the chair will work to optimize the practice through the design, development, evaluation, and prioritization of forward-looking, innovative models as well as develop its research and education portfolios. The chair will preferably be located in either Eau Claire, WI or Mankato, MN, and is responsible for developing the Hematology-Oncology department across MCHS in an integrated, coordinated, and efficient manner, and represents the MCHS perspective within the broader Mayo Clinic institution. 

Primary Responsibilities

The Chair is accountable for providing leadership and collaboration in fulfilling the following objectives for the Hematology-Oncology department in MCHS: 

• Facilitate the development and implementation of the MCHS Hematology-Oncology strategic plan by building multidisciplinary teams, ensuring project execution and executing performance. Responsible for overall operational performance, developing plans using a “Now, Near, Far” approach. 
• Work with the state and site-based chairs to provide operational, clinical and financial oversight for the MCHS states/regions. Track and communicate results/progress toward departmental performance measures and targets ensuring responsible resource allocation to achieve financial sustainability.   
• Strive to develop a consistent and replicable standard of care throughout MCHS by disseminating and directing best practices. 
• Provide inspired and effective leadership to MCHS physician colleagues (including recruitment, development, coaching, mentoring and succession planning activities) while keeping MCHS leadership informed of the performance of the Hematology-Oncology practice. 
• Ensure staff satisfaction and engagement through well-being, creating a culture of recognition and sense of belonging. Establish and maintain a regular onsite presence and build relationships to provide effective leadership, role modeling, mentorship and support. Create an environment of open dialogue and team engagement.
• Promote Mayo values and the Mayo Model of Care. Provide an environment that values diversity and enables people to develop their talents and do their best work, individually and together. 
• Provide ongoing communication of institutional, departmental and MCHS Hematology-Oncology practice issues to MCHS leadership. 
• Work with the Mayo Clinic Rochester residency/fellowship training programs to continue to grow partnerships and identify and appropriately train potential new staff members for careers in MCHS. 
• Lead the development of MCHS based cancer training programs (GME, medical student rotations)
• Collaborate with Mayo Clinic and MCCCC strategic initiatives to develop optimal models of cancer care delivery in community-based medicine, with an optimal model blending in-facility, home-based, and virtual care.
• Represent MCHS on the Mayo Clinic Hematology-Oncology Specialty Council, and the Leadership Committee of the MCCCC. 
• Lead the implementation of cancer genomic testing for MCHS patients to facilitate state-of-the art cancer care.

Desired Outcomes

• Elevate Hematology-Oncology Practice to Category One: Lead the Hematology-Oncology practice to become a premier, integrated service within MCHS, embodying excellence in quality, safety, efficiency, patient experience, and staff satisfaction.
• Expand Access to High-Quality Cancer Care: Increase patient access to specialized cancer care through the strategic expansion of services, including the integration of the community-based infusion centers and collaboration with Mayo Clinic Comprehensive Cancer Center.
• Build and expand a Cancer Clinical Trials Program across MCHS, starting with key pilot sites, to assure that MCHS cancer patients have access and engage in state-of-the-art cancer clinical trials suitable for a community setting, including cancer prevention, screening, and treatment.
• Integrate and Coordinate Across Regions: Develop and manage a highly integrated and coordinated Hematology-Oncology healthcare service across MN, WI, and IA that aligns with the Mayo Clinic care model, ensuring fiscal success and high-quality patient care.

Ideal Experience

The Chair must be an M.D. or M.D./Ph.D., be clinically and scientifically active, and will remain so during their tenure. Must be board-certified in medical hematology/oncology.  The successful candidate will hold an academic rank as Associate Professor or Professor. 

Successful leadership role in academic medicine or community healthcare with experience in leading growth of cancer services. The ideal candidate will have a solid track record in enhancing oncology and hematology services, recruitment, team building, visionary strategy setting, and making impactful decisions for clinical, research and financial results. Strong strategic planning, interpersonal, leadership, and communication abilities are essential.

The role requires innovation, bold leadership, and a commitment to integrating research, clinical care, and patient services in an evolving healthcare environment.

Prior experience with National Cancer Institute (NCI)-sponsored, industry-sponsored and or investigator-initiated trials is preferred. While the successful applicant and MCHS will be provided with significant financial and operational support, the successful candidate will have familiarity with regulatory requirements, patient recruitment strategies, and biomarker-driven trial design. A track record of publishing research finding and presenting at international conferences further accentuates the desired profiles. It is anticipated that the chair will recruit for and grow research within the program.

MD, DO or foreign degree equivalent and eligibility for licensure in Minnesota and Wisconsin are required. Must be board-certified in hematology/medical oncology and hold current academic rank of Associate Professor or Professor.